Skip to main content
. 2023 Aug 7;23:829. doi: 10.1186/s12913-023-09738-4

Table 1.

Eligible Population and Effectiveness Assumptions for Minimum and Maximum Scenarios

Cancer Type Minimum Scenario Maximum Scenario
1st Year
USPSTF Recommendation
Eligible
Population
Life-Years Gained per Screened Individual 1st Year USPSTF Recommendation Eligible Population Life-Years Gained per Screened Individual
Breast 1996 Women; age 50–69 y 0.029 [22] 1996 Women, age 40 + y 0.044 [22]
Colorectal 1996 Age 50–75 y Flex sig + FITa: 0.009 [23] 2002 Age 45–75 y Colonoscopy: 0.022 [23]
Cervical 1996 Women; age 21–65 y

PAPb:

0.089 [24]

1996 Women; age 21–65 y 21–30 PAP; 30–65 cotestingc: 0.096 [24]
Lung 2014 Current smoker or former smoker; age 50–80 y 0.0316 [25] Limited benefit evidence, same as minimum scenario

aFlex sig: flexible sigmoidoscopy, an endoscopic procedure that allows physician to examine the rectum and lower colon

bPAP: a Pap smear or Pap test is a screening test for cervical cancer

cCotesting: combination of PAP and human papilloma virus testing

FIT, fecal immunochemical test; USPSTF, US Preventive Services Task Force